Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry

Journal of the American College of Cardiology

Volumn 65, Issue 16, 2015, Pages 1605-1615

  Burke, Martin C ^a   Gold, Michael R ^b   Knight, Bradley P ^c   Barr, Craig S ^d   Theuns, Dominic A M J ^e   Boersma, Lucas V A ^f   Knops, Reinoud E ^g   Weiss, Raul ^h   Leon, Angel R ⁱ   Herre, John M ^j   Husby, Michael ^k   Stein, Kenneth M ^k   Lambiase, Pier D ^l  

^a UNIVERSITY OF CHICAGO   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d RUSSELLS HALL HOSPITAL   (United Kingdom)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ST ANTONIUS HOSPITAL   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h OHIO STATE UNIVERSITY   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j Sentara Cardiology Specialists   (United States)

^k Boston Scientific   (United States)

^l UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

more..

Author keywords

pacing; rhythm disorders; tachyarrhythmias; ventricular fibrillation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEVICE SAFETY; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE PACING; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INAPPROPRIATE SHOCK; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTCOME ASSESSMENT; PACEMAKER ELECTRODE; PACEMAKER IMPLANTATION; POCKET EROSION; PRIORITY JOURNAL; PROSTHESIS INFECTION; PROSTHESIS LOOSENING; SUPRAVENTRICULAR TACHYCARDIA; ADVERSE EFFECTS; EQUIPMENT DESIGN; MIDDLE AGED; PROSPECTIVE STUDY; REGISTER; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 84928019174     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.02.047     Document Type: Article

References (23)

1. G.H. Bardy, W.M. Smith, and M.A. Hood et al. An entirely subcutaneous implantable cardioverter-defibrillator N Engl J Med 363 2010 36 44
2. R. Weiss, B.P. Knight, and M.R. Gold et al. Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator Circulation 128 2013 944 953
3. P.D. Lambiase, C. Barr, and D.A. Theuns et al. Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry Eur Heart J 35 2014 1657 1665
4. L.R. Olde Nordkamp, L. Dabiri Abkenari, and L.V. Boersma et al. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort J Am Coll Cardiol 60 2012 1933 1939
5. M.R. Gold, R. Weiss, and D.A. Theuns et al. Use of a discrimination algorithm to reduce inappropriate shocks with a subcutaneous implantable cardioverter-defibrillator Heart Rhythm 11 2014 1352 1358
6. C.W. Israel, and S.S. Barold Electrical storm in patients with an implanted defibrillator: a matter of definition Ann Noninvasive Electrocardiol 12 2007 375 382
7. G.H. Bardy, K.L. Lee, and D.B. Mark et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
8. A.J. Moss, W. Zareba, and W.J. Hall et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 346 2002 877 883
9. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators N Engl J Med 337 1997 1576 1583
10. A.J. Moss, C. Schuger, and C.A. Beck et al. Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
11. J.S. Healey, S.H. Hohnloser, and M. Glikson et al. Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE) Lancet 385 2015 785 791
12. R.E. Knops, L.R. Olde Nordkamp, J.R. de Groot, and A.A. Wilde Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator Heart Rhythm 10 2013 1240 1243
13. J.V. Freeman, Y. Wang, J.P. Curtis, P.A. Heidenreich, and M.A. Hlatky Physician procedure volume and complications of cardioverter-defibrillator implantation Circulation 125 2012 57 64
14. P.N. Peterson, P.D. Varosy, and P.A. Heidenreich et al. Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention JAMA 309 2013 2025 2034
15. J.B. van Rees, M.K. de Bie, J. Thijssen, C.J. Borleffs, M.J. Schalij, and L. van Erven Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials J Am Coll Cardiol 58 2011 995 1000
16. C.D. Swerdlow, A.M. Russo, and P.J. Degroot The dilemma of ICD implant testing Pacing Clin Electrophysiol 30 2007 675 700
17. M.R. Gold, S. Higgins, and R. Klein et al. Efficacy and temporal stability of reduced safety margins for ventricular defibrillation: primary results from the Low Energy Safety Study (LESS) Circulation 105 2002 2043 2048
18. Y.M. Cha, D.L. Hayes, and S.J. Asirvatham et al. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study Heart Rhythm 10 2013 702 708
19. V. Kutyifa, A.C. Huth Ruwald, and M.K. Aktas et al. Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT J Cardiovasc Electrophysiol 24 2013 1246 1252
20. J.E. Poole, and M.R. Gold Who should receive the subcutaneous implanted defibrillator? The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing Circ Arrhythm Electrophysiol 6 2013 1236 1244 discussion 1244-5
21. M.S. Wathen, P.J. DeGroot, and M.O. Sweeney et al. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results Circulation 110 2004 2591 2596
22. K.M. Kooiman, R.E. Knops, L. Olde Nordkamp, A.A. Wilde, and J.R. de Groot Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management Heart Rhythm 11 2014 426 434
23. M.R. Gold, D.A. Theuns, and B.P. Knight et al. Head-to-head comparison of arrhythmia discrimination performance of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study J Cardiovasc Electrophysiol 23 2012 359 366